Tekturna Recall

Tekturna (aliskiren) is a high blood pressure medication that has the potential to cause harm to the heart and renal system.

Tekturna Causes Heart and Kidney Issues When Used With Other Heart Medications

High blood pressure or hypertension is an issue that requires medication to bring it under control. Untreated high blood pressure is known as a silent killer, and treatment tends to see aggressive use of medications. Keeping the blood pressure low and steady is of the utmost importance. Tekturna was introduced to the market as a new drug in the arsenal against high blood pressure. However, the drug was found to be not all that it seemed.

Tekturna is safe for most of the population except those with Type II diabetes. A study found that taking the combination of Tekturna and an angiotensin converting enzyme (ACE) or angiotensin receptor blocker (ARB) inhibitor by patients with Type II diabetes wound up with near-fatal cardiac events and kidney issues.

Those with Type II diabetes were found to have increased complications such as renal failure and stroke than individuals with Type II diabetes who did not take the medication. It was also found that the events could occur 18 to 24 months after the medication had been discontinued.

The maker of Tekturna, Novartis, made a poor decision to promote the safety of Tekturna for long-term use by diabetics long before the trial was over. It also made the decision to promote the medication and its variations for off-label use by diabetics, making the claim that the drug had a protective effect. Yet, the drug had no specific instruction on the labeling that it was safe for use in diabetic patients.

Novartis put the cart before the horse when it came to Tekturna, causing unnecessary harm to patients who thought they were taking a life-improving medication.

The Known Complications and Side Effects From Taking Tekturna With an ACE/ARB Inhibitor

Tekturna mainly affected the heart, although other complications were noted after taking the medication in combination with an ACE or ARB inhibitor.

Some of the side effects include:

  • Sudden cardiac arrest with successful resuscitation
  • High levels of potassium in the blood known as hyperkalemia
  • Low blood pressure known as hypotension
  • Stroke that did not result in a fatality
  • Sudden heart death
  • Complications with the kidneys
  • Increase in creatinine concentration resulting in end stage kidney disease

Tekturna also causes angioedema, which is an allergic reaction that results in swelling of the face, lips, throat and tongue. It can also affect extremities such as feet and hands.

Have You or a Loved One Suffered Complications After Taking Tekturna?

Novartis made a bad decision by promoting Tekturna as safe for Type II diabetics to use before the study was over. As a result, patients suffered unnecessarily from taking the combination of Tekturna and ACE/ARB inhibitors. If you or a loved one have experienced an adverse event after taking Tekturna, you may be able to file suit against Novartis.

Contact a lawyer about reviewing your case. You may be eligible to sue for damages that were received as a result of taking a defective drug.

  • Comments:

    When authoring your comments please try to include the Who? What? Where? When? and How?

    The more information our attorneys have the better they can evaluate your potential claim.

  • This field is for validation purposes and should be left unchanged.